{"id":116,"date":"2025-09-30T13:44:55","date_gmt":"2025-09-30T13:44:55","guid":{"rendered":"https:\/\/www.theisn.org\/frontiers\/?page_id=116"},"modified":"2026-09-01T12:09:34","modified_gmt":"2026-09-01T12:09:34","slug":"program","status":"publish","type":"page","link":"https:\/\/www.theisn.org\/frontiers\/program\/","title":{"rendered":"Program"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour el_class=”hide”][vc_tab title=”Day 1 – September 5, 2026″ tab_id=”eeecde79-4372-6″][\/vc_tab][vc_tab title=”Day 2 – September 6, 2026″ tab_id=”1759236180933-1-9″][\/vc_tab][vc_tab title=”Day 3 – September 7, 2026″ tab_id=”1759236181786-2-4″][\/vc_tab][\/vc_tour][\/vc_column][\/vc_row][vc_row][vc_column][vc_tabs el_class=”hide”][vc_tab title=”Day 1 – September 5, 2026″ tab_id=”25306389-f924-6″][\/vc_tab][vc_tab title=”Day 2 – September 6, 2026″ tab_id=”1787216449622-2-10″][\/vc_tab][vc_tab title=”Day 3 – September 7, 2026″ tab_id=”1787216463448-3-2″][\/vc_tab][\/vc_tabs][\/vc_column][\/vc_row][vc_row][vc_column][vc_tta_accordion c_position=”right” active_section=”1″ collapsible_all=”true” el_class=”accordion-isn”][vc_tta_section title=”Day 1 – September 5, 2026″ tab_id=”day1″][vc_column_text]<\/p>\n

\n\n\n\n<\/colgroup>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Pre-meeting symposia<\/th>\n<\/tr>\n
14:30 \u2013 15:00<\/td>\nClinical Application of Amino Acid-based Dialysis Solution\u00a0<\/span><\/td>\n<\/tr>\n
15:00 \u2013 15:30<\/td>\nCentral Mechanisms of Kappa Opioids in Itch Control\u00a0<\/span><\/td>\n<\/tr>\n
15:30 \u2013 16:00<\/td>\nDecoding Pruritus, Achieving Comprehensive Benefits\u00a0<\/span><\/td>\n<\/tr>\n
Welcome and Opening Session
\nSession moderators: Liz Lightstone, UK | Guang-yan Cai, China |\u00a0 Hongli Lin, China<\/em>
\n<\/span><\/th>\n<\/tr>\n
17:00 – 17:06<\/td>\nOpening Address from the ISN – Liz Lightstone, UK<\/em><\/strong><\/td>\n<\/tr>\n
17:06 – 17:09<\/td>\nWelcome Address from the CSN and ISN Frontiers Co-chair – Guang-yan Cai, China<\/em><\/strong><\/td>\n<\/tr>\n
17:09 – 17:12<\/td>\nWelcome Address from the CSN – Xiaoqiang Ding, China<\/strong><\/em><\/td>\n<\/tr>\n
17:12 – 17:14<\/td>\nWelcome from Dalian Medical University – Ying Liu , China<\/em><\/strong><\/td>\n<\/tr>\n
17:14 – 17:16<\/td>\nWelcome from Dalian Medical University – Hongli Lin, China<\/em><\/strong><\/td>\n<\/tr>\n
17:18 – 17:21<\/td>\nWelcome and Opening Remarks by ISN Frontiers Co-chair – Masaomi Nangaku, Japan<\/strong>\u00a0<\/em><\/td>\n<\/tr>\n
17:21 – 17:24<\/td>\nWelcome and Opening Remarks by ISN Frontiers Co-chair –\u00a0Sola Aoun Bahous, Lebanon<\/strong><\/em><\/td>\n<\/tr>\n
17:25 – 18:05<\/td>\nBuilding AI Knowledge for Nephrology Practice – Sola Aoun Bahous, Lebanon<\/em><\/strong><\/td>\n<\/tr>\n
18:05 – 18:45<\/td>\nWhy Kidney Registries Matter\u00a0 – Fergus Caskey, UK<\/em><\/strong><\/td>\n<\/tr>\n
Welcome & Networking Reception<\/strong> (18:45 – 20:00)<\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Day 2 – September 6, 2026″ tab_id=”day2″][vc_column_text]<\/p>\n

\n\n\n\n<\/colgroup>\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session 2: Keynote<\/p>\n

Session moderator: Liz Lightstone, UK<\/span><\/em><\/th>\n<\/tr>\n

09:00 – 09:40<\/td>\nMRAs for Cardio-Kidney-Metabolic Health – Peter Rossing, Denmark<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Coffee Break and Poster Viewing (09:40 – 10:10)<\/th>\n<\/tr>\n

<\/p>\n

Session 3: Rare Kidney Diseases: From Mechanisms to Implementation<\/p>\n

Session moderators:\u00a0 Masaomi Nangaku, Japan | Meg Jardine, Australia<\/span><\/em><\/th>\n<\/tr>\n

10:10 \u2013 10:35<\/td>\nEndothelin A Receptor Antagonists in IgA Nephropathy – Meg Jardine, Australia<\/em><\/strong><\/td>\n<\/tr>\n
10:35 \u2013 11:00<\/td>\nHow Complement Pathways Drive IgA Nephropathy – Sung Gyun Kim, South Korea<\/em><\/strong><\/td>\n<\/tr>\n
11:00 \u2013 11:25<\/td>\nB cell-targeted therapies for IgA nephropathy – Sydney Tang, Hong Kong, China<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Industry symposia
\n(Lunch will be served in the room only)<\/span><\/em><\/th>\n<\/tr>\n
11:35 – 12:35<\/td>\nUshering in a New Curative Era for IgAN – From Pathogenesis to Precision Targeting<\/td>\n<\/tr>\n
12:40 – 13:10<\/td>\n2026 Hot Topics in Chronic Kidney Disease and Hyperkalemia<\/td>\n<\/tr>\n

<\/p>\n

Session 4: Innovations in AKI: From Lab to Clinic<\/p>\n

Session moderators: Motoko Yanagita, Japan | Minghui Zhao, China<\/span><\/em><\/th>\n<\/tr>\n

13:15 – 13:40<\/td>\nLinking Molecular Pathways to AKI Outcomes – Motoko Yanagita, Japan<\/em><\/strong><\/td>\n<\/tr>\n
13:40 – 14:05<\/td>\nCan AI Detect AKI Early? – Sejoong Kim, South Korea<\/em><\/strong><\/td>\n<\/tr>\n
14:05 – 14:30<\/td>\nProtecting Kidneys in Cardiac Surgery: The RIPC Approach – Xiaoqiang Ding, China<\/em><\/strong><\/td>\n<\/tr>\n
14:30 – 14:55<\/td>\nStem Cell Therapy for AKI: From Bench to Bedside – Guang-yan Cai, China<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Coffee Break and Poster Viewing (14:55 – 15:25)<\/th>\n<\/tr>\n

<\/p>\n

Session 5: Implementing Cardio-Kidney-Metabolic Care: From Mechanisms to Global Burden<\/p>\n

Session moderators: Sunita Bavanandan, Malaysia | Guang-yan Cai, China<\/span><\/em><\/th>\n<\/tr>\n

15:25 – 15:50<\/td>\nMolecular Mechanisms of Cardio-Kidney-Metabolic Syndrome – Jin Joo Cha, South Korea<\/em><\/strong><\/td>\n<\/tr>\n
15:50 – 16:15<\/td>\nBurden of Cardio-Kidney-Metabolic Syndrome in Asia – Sunita Bavanandan, Malaysia<\/em><\/strong><\/td>\n<\/tr>\n
16:15 – 16:40<\/td>\nCardio-Kidney-Metabolic Syndrome: An Integrated Approach to the Global Health Burden – Pringgodigdo Nugroho, Indonesia<\/em><\/strong><\/td>\n<\/tr>\n
16:40 – 17:05<\/td>\nThe role of the ISN in implementation of cardiovascular-kidney-metabolic care – Adeera Levin, Canada<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Industry Symposium<\/strong><\/th>\n<\/tr>\n
17:05 – 18:05<\/td>\nNon-steroidal MRAs: Redefining Care in CKM<\/td>\n<\/tr>\n

<\/p>\n

Networking Dinner<\/strong> (18:10 – 20:00)<\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

[\/vc_column_text][\/vc_tta_section][vc_tta_section title=”Day 3 – September 7, 2026″ tab_id=”day3″][vc_column_text]<\/p>\n

\n\n\n\n<\/colgroup>\n<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
Session 6: Keynote
\nSession moderator: Fergus Caskey, UK<\/span><\/em><\/th>\n<\/tr>\n
08:30 – 09:10<\/td>\nTelemedicine and AI for Smarter Nephrology Practice – Masaomi Nangaku, Japan<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Session 7: Application of Artificial Intelligence and Digital Transformation in Kidney Care
\nSession moderators: Sola Aoun Bahous, Lebanon | Xiaoqiang Ding, China<\/span><\/em><\/th>\n<\/tr>\n
09:15 – 09:30<\/td>\nAI and Kidney Disease – Lu-Xia Zhang, China<\/em><\/strong><\/td>\n<\/tr>\n
09:30 – 09:45<\/td>\nAI in Transplantation Pathology – Alton B Farris, USA<\/em><\/strong><\/td>\n<\/tr>\n
09:45 – 10:00<\/td>\nMulti-Stain Deep Learning Model to Predict Treatment Response in Lupus Nephritis – Wei Chen, China<\/em><\/strong><\/td>\n<\/tr>\n
10:00 – 10:15<\/td>\nUnveiling Kidney Disease Through Body Gas Sensing Techniques – Yosuke Hirakawa, Japan<\/em><\/strong><\/td>\n<\/tr>\n

<\/p>\n

Coffee Break and Poster Viewing (10:15 – 10:45)<\/th>\n<\/tr>\n

<\/p>\n

Session 8: Innovations in Blood Purification for Kidney Disease
\nSession moderators: Kornchanok Vareesangthip, Thailand | Bicheng Liu, China<\/span><\/em><\/th>\n<\/tr>\n
10:45 – 11:10<\/td>\nGlycation End Products and Kidney Disease – Kornchanok Vareesangthip, Thailand<\/em><\/strong><\/td>\n<\/tr>\n
11:10 – 11:35<\/td>\nPeritoneal Dialysis: Advances and Challenges – Winston Fung, Hong Kong, China<\/em><\/strong><\/td>\n<\/tr>\n
11:35 – 12:00<\/td>\nHIF Inhibitors: Transforming Anaemia Care – Ping Li, China<\/em><\/strong><\/td>\n<\/tr>\n
12:00 – 12:25<\/td>\nNovel Blood Purification Approaches in Kidney Care – Hong-Li Lin, China<\/em><\/strong><\/td>\n<\/tr>\n
12:25 – 12:40<\/td>\nAbstract Oral Presentation – Yuhang Ma, China <\/em><\/strong>:
\nMachine Learning\u2013Based Short-Term Prognostic Models for IgA Nephropathy: A Multicenter Development and Validation Study<\/em>
\n<\/span><\/td>\n<\/tr>\n

<\/p>\n

Industry symposia
\n<\/strong>(Lunch will be served in the room only)<\/em><\/span><\/th>\n<\/tr>\n
12:50 – 13:20<\/td>\nNon-steroidal MRAs: Reshaping CKD Care Landscape<\/td>\n<\/tr>\n
13:25 – 13:55<\/td>\nAdvances in the Diagnosis and Treatment of Membranous Nephropathy<\/td>\n<\/tr>\n

<\/p>\n

Session 9: Research and Trials Driving Advances in Rare Kidney Diseases
\nSession moderators: Sydney Tang, Hong Kong, China | Chun Zhang, China<\/span><\/em><\/th>\n<\/tr>\n
14:10 – 14:35<\/td>\nRare Kidney Diseases from a Patient Perspective – Bill Wang, Hong Kong, China<\/em><\/strong><\/td>\n<\/tr>\n
14:35 – 15:00<\/td>\nRare Kidney Diseases in China: Challenges and Progress – Li-Meng Chen, China<\/em><\/strong><\/td>\n<\/tr>\n
15:00 – 15:25<\/td>\nManaging Kidney Involvement in Lupus – Liz Lightstone, UK<\/em><\/strong><\/td>\n<\/tr>\n
15:25 – 15:50<\/td>\nImproving Outcomes for Children With Rare Kidney Disease – Hong Xu, China<\/em><\/strong><\/td>\n<\/tr>\n
15:50 – 16:05<\/td>\nAbstract Oral Presentation – Jia Chen, China<\/em><\/strong>:
\nTargeted intervention for DcR2 alleviates acute kidney injury by modulating tubular senescence<\/em>
\n<\/span><\/td>\n<\/tr>\n

<\/p>\n

Young Nephrologist Award Ceremony (16:05 – 16:10)<\/th>\n<\/tr>\n

<\/p>\n

Coffee Break and Poster Viewing (16:10 – 16:40)<\/th>\n<\/tr>\n

<\/p>\n

Session 10: Advances in CKM Care and Closing Remarks
\nSession moderators: Guang-yan Cai, China | Sola Aoun Bahous, Lebanon | Masaomi Nangaku, Japan<\/span><\/em><\/th>\n<\/tr>\n
16:40 – 17:05<\/td>\nIntegrating GLP-1RA Into Cardio-Kidney-Metabolic Management – Sydney Tang, Hong Kong, China<\/em><\/strong><\/td>\n<\/tr>\n
17:05 – 17:30<\/td>\nSGLT2i for CKD: Expanding Benefits Beyond Diabetes – Xiao-Xi Zeng, China<\/em><\/strong><\/td>\n<\/tr>\n
17:30 – 17:45<\/td>\nAbstract Oral Presentation – Li Zhu, China<\/em><\/strong>:
\nCarnitine Acetyltransferase Attenuates Chronic Kidney Disease-Related Cardiomyopathy via STAT3-Regulated Mitochondrial Dysfunction and Cardiomyocyte Hypertrophy<\/em>
\n<\/span><\/td>\n<\/tr>\n
17:45 – 18:05<\/td>\nReflections and Closing Remarks From the ISN Frontiers Co-chairs – Sola Aoun Bahous, Lebanon | Guang-yan Cai, China | Masaomi Nangaku, Japan<\/em><\/strong><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n

[\/vc_column_text][\/vc_tta_section][\/vc_tta_accordion][\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text][\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"

[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour el_class=”hide”][vc_tab title=”Day 1 – September 5, 2026″ tab_id=”eeecde79-4372-6″][\/vc_tab][vc_tab title=”Day 2 – September 6, 2026″ tab_id=”1759236180933-1-9″][\/vc_tab][vc_tab title=”Day 3 – September 7, 2026″ tab_id=”1759236181786-2-4″][\/vc_tab][\/vc_tour][\/vc_column][\/vc_row][vc_row][vc_column][vc_tabs el_class=”hide”][vc_tab title=”Day […]<\/p>\n","protected":false},"author":2,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-116","page","type-page","status-publish","hentry"],"yoast_head":"\nProgram - ISN Frontiers Meetings<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.theisn.org\/frontiers\/program\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Program - ISN Frontiers Meetings\" \/>\n<meta property=\"og:description\" content=\"[vc_row][vc_column][vc_column_text]The upcoming ISN Frontiers Meeting in Dalian, China, will focus on novel treatments for kidney disease and feature a focused, single-track agenda exploring the latest innovations in treatment over two days.[\/vc_column_text][vc_tour el_class=”hide”][vc_tab title=”Day 1 – September 5, 2026″ tab_id=”eeecde79-4372-6″][\/vc_tab][vc_tab title=”Day 2 – September 6, 2026″ tab_id=”1759236180933-1-9″][\/vc_tab][vc_tab title=”Day 3 – September 7, 2026″ tab_id=”1759236181786-2-4″][\/vc_tab][\/vc_tour][\/vc_column][\/vc_row][vc_row][vc_column][vc_tabs el_class=”hide”][vc_tab title=”Day […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.theisn.org\/frontiers\/program\/\" \/>\n<meta property=\"og:site_name\" content=\"ISN Frontiers Meetings\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-01T12:09:34+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.theisn.org\/frontiers\/#website\",\"url\":\"https:\/\/www.theisn.org\/frontiers\/\",\"name\":\"ISN Frontiers Meetings\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":\"https:\/\/www.theisn.org\/frontiers\/?s={search_term_string}\",\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.theisn.org\/frontiers\/program\/#webpage\",\"url\":\"https:\/\/www.theisn.org\/frontiers\/program\/\",\"name\":\"Program - ISN Frontiers Meetings\",\"isPartOf\":{\"@id\":\"https:\/\/www.theisn.org\/frontiers\/#website\"},\"datePublished\":\"2025-09-30T13:44:55+00:00\",\"dateModified\":\"2026-09-01T12:09:34+00:00\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.theisn.org\/frontiers\/program\/\"]}]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","_links":{"self":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116"}],"collection":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/comments?post=116"}],"version-history":[{"count":12,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116\/revisions"}],"predecessor-version":[{"id":848,"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/pages\/116\/revisions\/848"}],"wp:attachment":[{"href":"https:\/\/www.theisn.org\/frontiers\/wp-json\/wp\/v2\/media?parent=116"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}